SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019056-14-000872
Filing Date
2014-06-23
Accepted
2014-06-23 13:57:14
Documents
1
Period of Report
2014-06-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT vogel_4.html 4  
1 OWNERSHIP DOCUMENT vogel_4.xml 4 23061
  Complete submission text file 0001019056-14-000872.txt   24363
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MEADOW DRIVE LAWRENCE NY 11559
Business Address
Vogel Jeffrey Kenneth (Reporting) CIK: 0001348315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 14934799